BioCentury
ARTICLE | Company News

UCB, Harvard in microbiome research deal

October 11, 2012 12:57 AM UTC

UCB Group (Euronext:UCB) will provide up to $4.5 million over three years for research at Harvard University to study the human microbiome in the intestine. The project will focus on classifying new s...